Purchase Order 75N92023P00301
Award Date
8/18/23
Potential Completion Date
8/17/25
Potential Value
$126K
Funding Federal Agency
National Human Genome Research Institute
Contracting Federal Agency
National Heart Lung and Blood Institute
Awardee
Cerba Research Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
R499 - Support- Professional: Other
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New Hyde Park, NY 11042, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute to Cerba Research USA Inc., a for-profit organization that provides clinical trial and laboratory services to support biomedical research. The $108,028.00 fixed-price purchase order is for Cerba Research to provide clinical laboratory testing and associated data management services, to be performed at the company's New York laboratory. No subcontractors...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a Firm Fixed Price Purchase Order to Cerba Research USA, Inc., a for-profit organization, to conduct research and assay serum biomarkers. The $66,334.00 contract has a completion date of June 30, 2022. Cerba Research USA, Inc. will perform the work at its laboratory in New Hyde Park, New York and has not indicated any subcontractors. Cerba Research USA, Inc. holds additional...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Cerba Research USA, Inc. for SARS-CoV-2 testing support. The total award value is $1,382,498.14, with a total ceiling of $1,615,094.14. The period of performance runs through December 31, 2023. This award is not associated with a larger contract vehicle, and no set-aside designation was used. Cerba...
This is a firm fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Cerba Research USA, Inc., a for-profit organization. The $529,892 award will fund clinical central laboratory services in support of three NIAID clinical protocols related to infectious diseases. This work will be performed at Cerba Research's facility in New Hyde Park, New York. The award is not associated...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute awarded a $112,198.00 firm fixed price purchase order to Cerba Research USA Inc., a for-profit organization, to procure the services of BARC to assay serum biomarkers. The work is to be performed in Bethesda, Maryland and there are no set-aside designations or subcontractors indicated. Cerba Research USA Inc. is a clinical trial and laboratory services provider that...
This is a federal contract award to Laboratory Corporation of America (Labcorp), a leading global life sciences company, by the National Human Genome Research Institute (NHGRI), a civilian agency under the Department of Health and Human Services. The contract, valued at $62,375.00, is a firm-fixed-price Delivery Order under Labcorp's General Services Administration (GSA) Federal Supply Schedule contract for Medical Laboratory Testing and Analysis Services (FSS-621-II). The contract is not set...
This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to SBH Sciences Inc. on June 12, 2018. The contract has a ceiling value of $8,300 and an ultimate completion date of August 31, 2020. The contract is not designated as a set-aside. Based on the information provided, this award appears to be for a specific product or service required by NHGRI, which is the lead National Institutes of Health (NIH) institute responsible...
This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Reprocell U.S.A., Inc. for $17,016.80. The contract was awarded on January 5, 2023 with a completion date of July 5, 2023. The contract supports genetic and epigenetic analysis at the transcriptome level, which is a critical component of the Comprehensive Disease Study (CDS) program's integrative research...
<p>This is a firm fixed-price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Inbiomedic Sac, a for-profit limited liability company based in Peru, for $22,771.64 in research services. The contract has a period of performance through November 15, 2025 and does not have a set-aside designation. No additional information about larger contract vehicles or subcontractors is provided.</p>
This is a $93,300.00 firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Cisbio US, Inc., a foreign-owned for-profit company, for the provision of 10,000 HISTONE2 HTRF Assay test kits. The award was not set aside. Cisbio US, Inc. has previously provided assay kits, cell lines, and collagen reagents related to disease research to various Department of Health and Human Services (HHS) agencies, including the NIH, Centers for Disease Control and...